Profile
Hilary Webber is currently the Chairman at Eqalis Pharmaceuticals Ltd.
Previously, Ms. Webber worked as an Independent Non-Executive Director at Cannasouth Ltd.
Hilary Webber active positions
| Companies | Position | Start |
|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Chairman | - |
Former positions of Hilary Webber
| Companies | Position | End |
|---|---|---|
| CANNASOUTH LIMITED | Director/Board Member | 2023-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Stock Market
- Insiders
- Hilary Webber
